The fructose analogue 2,5-anhydro-D-mannitol (2,5-AM), that inhibits g
lucose release and ATP formation in liver cells, seems to stimulate fe
eding by acting on the liver, because hepatic portal injection was mor
e effective than jugular vein injection and because hepatic branch vag
otomy attenuated 2,5-AM's hyperphagic effect. Russek's ''potentiostati
c'' hypothesis postulates a role for the hepatic membrane potential in
the control of food intake with depolarization of hepatocytes signali
ng hunger and hyperpolarization representing a satiety signal. Therefo
re, the aim of the present study was to find out, whether 2,5-AM affec
ts the hepatic membrane potential under ill vivo conditions. The membr
ane potential was measured with microelectrodes in anesthetized rats a
fter intraperitoneal (IF) or intraportal (IPV) administration of 2,5-A
M or control solution. 2,5-AM significantly hyperpolarized the hepatoc
yte membrane 50 min after IP injection (100 mg/kg: 3.6 mV; 300 mg/kg:
9.9 mV). In a second experiment, 2,5-AM (300 mg/kg) elicited a signifi
cant hyperpolarization of hepatocytes as soon as 5 - 9 min after IPV i
nfusion. These effects occured at doses that have been shown to increa
se the afferent discharge rate in the common hepatic vagus branch, and
to stimulate food intake, 2,5-AM's hyperphagic effect therefore is as
sociated with an increase in the hepatic membrane potential. These fin
dings contradict the predictions of the ''potentiostatic'' hypothesis
and-are consistent with the notion, that the feeding response to 2,5-A
M might be due to ATP depletion in the terminals of vagal afferents.